CGEM FY 2024 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

FY 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$306,000

Operating Income

-$197M

Net Income

-$167M

EPS (Diluted)

$-3.11

Cash Flow

Operating Cash Flow

-$145M

Free Cash Flow

-$145M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$622M

Total Liabilities

$31M

Stockholders' Equity

$590M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$306,000	$0	—
Operating Income	-$197M	-$191M	-3.1%
Net Income	-$167M	-$153M	-9.3%